Susquehanna International Group
MDVX

Susquehanna International Group’s Medovex Corp. Common Stock MDVX Stock Holding History

Susquehanna International Group’s Portfolio MDVX Stock Details MDVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,288
Closed -$20K – 10687
2016
Q4 		$20K Buy
+15,288
New +$22.7K ﹤0.01% 9430
2016
Q2 		– Sell
-15,093
Closed -$16K – 9832
2016
Q1 		$16K Buy
+15,093
New +$18.8K ﹤0.01% 8843

Other funds holding MDVX

MIC
Meridian Investment Counsel Lafayette, California $466M AUM 42.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group's MDVX Position: Q1 2017 in Review

Susquehanna International Group sold out of Medovex Corp. Common Stock (MDVX) in Q1 2017, closing a stake of 15,288 shares — an estimated $20K sold.

Susquehanna International Group first reported a position in MDVX in Q1 2016 and held it in 2 quarters. The position peaked at $20K in Q4 2016. 6 funds tracked by Wall St. Rank hold MDVX as of Q1 2017.

  • Susquehanna International Group reported no remaining Medovex Corp. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Susquehanna International Group sold 15,288 Medovex Corp. Common Stock shares in Q1 2017, an estimated $20K.
  • Susquehanna International Group first reported a position in Medovex Corp. Common Stock in Q1 2016 and held it in 2 quarters.
  • Susquehanna International Group's Medovex Corp. Common Stock position peaked at $20K in Q4 2016.
  • 6 funds tracked by Wall St. Rank held Medovex Corp. Common Stock as of Q1 2017.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.